KRAS and non-small cell lung carcinoma: Importantly, a similar reduction in DPP4 expression was observed when LKB1 was depleted in the KRAS wild-type NSCLC cell line H1793, further indicating that DPP4 downregulation is primarily driven by LKB1 loss rather than KRAS mutation status (Supplementary Fig. S2E).